nelfinavir has been researched along with hyperoside in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chia, CSB; Shuyi Ng, P; Xu, W | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for nelfinavir and hyperoside
| Article | Year |
|---|---|
A Patent Review on SARS Coronavirus Main Protease (3CL
Topics: Antiviral Agents; Coronavirus 3C Proteases; Cysteine Proteinase Inhibitors; Drug Discovery; Humans; Patents as Topic; Protein Conformation; Structure-Activity Relationship | 2022 |
1 other study(ies) available for nelfinavir and hyperoside
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |